S. Vesalainen

742 total citations
16 papers, 589 citations indexed

About

S. Vesalainen is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Cancer Research. According to data from OpenAlex, S. Vesalainen has authored 16 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 5 papers in Rheumatology and 5 papers in Cancer Research. Recurrent topics in S. Vesalainen's work include Prostate Cancer Treatment and Research (15 papers), Prostate Cancer Diagnosis and Treatment (9 papers) and Cancer, Lipids, and Metabolism (5 papers). S. Vesalainen is often cited by papers focused on Prostate Cancer Treatment and Research (15 papers), Prostate Cancer Diagnosis and Treatment (9 papers) and Cancer, Lipids, and Metabolism (5 papers). S. Vesalainen collaborates with scholars based in Finland. S. Vesalainen's co-authors include P. Lipponen, Karí Syrjänen, Martti Talja, Stig Nordling, Ulf‐Håkan Stenman, Patrik Finne, Wanming Zhang, Jari Leinonen, P Lipponen and E. Alhava and has published in prestigious journals such as British Journal of Cancer, International Journal of Cancer and Clinical Chemistry.

In The Last Decade

S. Vesalainen

16 papers receiving 573 citations

Peers

S. Vesalainen

PRM

ONCOL

IMMUN

Sam Leung Canada

Noah Goodman United States

Billie‐Jo M. Kerns United States

Ecaterina Ileana France

Brett H. Simmons United States

Liana B. Guedes United States

Stephen Castaneda United States

Edward W. Arfman United States

Tove Øyjord Norway

Jesse McGreivy United States

Sam Leung Canada

S. Vesalainen

214 ×0.7

PRM

238 ×1.1

ONCOL

332 ×1.6

138 ×0.9

IMMUN

244 ×2.0

Citations per year, relative to S. Vesalainen S. Vesalainen (= 1×) peers Sam Leung

Countries citing papers authored by S. Vesalainen

Since Specialization

Citations

This map shows the geographic impact of S. Vesalainen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Vesalainen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Vesalainen more than expected).

Fields of papers citing papers by S. Vesalainen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Vesalainen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Vesalainen. The network helps show where S. Vesalainen may publish in the future.

Co-authorship network of co-authors of S. Vesalainen

This figure shows the co-authorship network connecting the top 25 collaborators of S. Vesalainen. A scholar is included among the top collaborators of S. Vesalainen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Vesalainen. S. Vesalainen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Lintula, Susanna, S. Vesalainen, Antti Rannikko, et al.. (2004). Quantification of prostate specific antigen mRNA levels in circulation after prostatic surgery and endocrine treatment by quantitative reverse transcription‐polymerase chain reaction. Scandinavian Journal of Clinical and Laboratory Investigation. 64(2). 93–100. 11 indexed citations

Zhang, Wanming, Patrik Finne, Jari Leinonen, et al.. (1999). Measurement of the Complex between Prostate-specific Antigen and α1-Protease Inhibitor in Serum. Clinical Chemistry. 45(6). 814–821. 63 indexed citations

Zhang, Wanming, Patrik Finne, Jari Leinonen, et al.. (1998). Characterization and immunological determination of the complex between prostate-specific antigen and α2-macroglobulin. Clinical Chemistry. 44(12). 2471–2479. 62 indexed citations

Lipponen, P. & S. Vesalainen. (1997). Expression of the Apoptosis suppressing protein bcl-2 in prostatic adenocarcinoma is related to tumor malignancy. The Prostate. 32(1). 9–15. 30 indexed citations

Aaltomaa, S., P. Lipponen, S. Vesalainen, et al.. (1997). Value of Ki-67 Immunolabelling as a Prognostic Factor in Prostate Cancer. European Urology. 32(4). 410–415. 38 indexed citations

Lipponen, P., et al.. (1996). A prognostic score for prostatic adenocarcinoma based on clinical, histological, biochemical and cytometric data from the primary tumour.. PubMed. 16(4A). 2095–100. 5 indexed citations

Vesalainen, S., et al.. (1995). Nuclear morphometry is of independent prognostic value only in T1 prostatic adenocarcinomas. The Prostate. 27(2). 110–117. 15 indexed citations

Vesalainen, S. & P. Lipponen. (1995). Expression of retinoblastoma gene (Rb) protein in T12MO prostatic adenocarcinoma. Journal of Cancer Research and Clinical Oncology. 121(7). 429–433. 13 indexed citations

Vesalainen, S., Martti Talja, P. Lipponen, & Karí Syrjänen. (1995). Mitotic activity and prognosis in prostatic adenocarcinoma. The Prostate. 26(2). 80–86. 29 indexed citations

10.

Vesalainen, S., P. Lipponen, Martti Talja, & Karí Syrjänen. (1995). Biochemical Parameters as Prognostic Factors in Prostatic Adenocarcinoma. Acta Oncologica. 34(1). 53–59. 9 indexed citations

11.

Vesalainen, S., P Lipponen, Stig Nordling, Martti Talja, & Karí Syrjänen. (1995). Results of the primary treatment in T1-3M0 prostatic adenocarcinoma are dependent on tumour biology.. PubMed. 15(2). 569–73. 2 indexed citations

12.

Vesalainen, S., P. Lipponen, Martti Talja, Esko Alhava, & Karí Syrjänen. (1994). Proliferating cell nuclear antigen and p53 expression as prognostic factors in T1‐2MO prostatic adenocarcinoma. International Journal of Cancer. 58(2). 303–308. 27 indexed citations

13.

Vesalainen, S., Stig Nordling, P. Lipponen, Martti Talja, & Karí Syrjänen. (1994). Progression and survival in prostatic adenocarcinoma: a comparison of clinical stage, Gleason grade, S-phase fraction and DNA ploidy. British Journal of Cancer. 70(2). 309–314. 22 indexed citations

14.

Vesalainen, S., P Lipponen, Martti Talja, E. Alhava, & Karí Syrjänen. (1994). Tumor vascularity and basement membrane structure as prognostic factors in T1-2MO prostatic adenocarcinoma.. PubMed. 14(2B). 709–14. 53 indexed citations

15.

Vesalainen, S., P. Lipponen, Martti Talja, & Karí Syrjänen. (1994). Histological grade, perineural infiltration, tumour-infiltrating lymphocytes and apoptosis as determinants of long-term prognosis in prostatic adenocarcinoma. European Journal of Cancer. 30(12). 1797–1803. 204 indexed citations

16.

Mattila, J., et al.. (1983). Effects of Some Putative Amino Acid Neurotransmitters on the Stimulated TSH Secretion in Male Rats. Hormone Research. 17(1). 19–26. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact